Showing results (161-170 of 242) with videos related to
Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancerI F Dennis, J R Ramsay, P Workman, et al.The British Journal of Cancer. Supplement|June 1, 1978
Clinical studies with misonidazoleC R Wiltshire, P Workman, J V Watson, et al.Neoplasia (New York, N.Y.)|August 9, 2001
The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cellsV G Brunton, V J Fincham, G W McLean, et al.Journal of Neurochemistry|August 1, 1990
Analysis of carnosine, homocarnosine, and other histidyl derivatives in rat brainJ J O'Dowd, M T Cairns, M Trainor, et al.Anti-Cancer Drug Design|February 24, 2001
Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenolN J Lant, P McKeown, L R Kelland, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumorsR Rampling, G Cruickshank, A D Lewis, et al.Biochemical Pharmacology|September 1, 1990
Doxorubicin-3'-NH-oestrone-17-oxime-ethyl-carbonyl, a doxorubicin-oestrone conjugate that does not redox cycle in rat liver microsomesN G Hartman, L H Patterson, P Workman, et al.Clinical Pharmacology and Therapeutics|January 31, 2013
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistanceD Gonzalez de Castro, P A Clarke, B Al-Lazikani, et al.Cancer Surveys|January 1, 1993
Pharmacokinetics and early clinical studies of selected new drugsS B Kaye, P Workman, M A Graham, et al.Oncogene|March 6, 2007
p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanismI R Macpherson, S Hooper, A Serrels, et al.Pageof 25